No Detail Found!

Safety and efficacy of sitagliptin compared with glimepiride in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy.

Author(s)
Amjad A Abrar Department of Cardiology, Gomal Medical College, Dera Ismail Khan, Pakistan
Shimal Khan Department of Cardiology, Gomal Medical College, Dera Ismail Khan, Pakistan
Mehboob-ur-Rehman Department of Cardiology, Institute of Medical Sciences, Islamabad Pakistan
Tehmina Jan Department of Cardiology, Pakistan Institute of Medical Sciences, Islamabad Pakistan
Muhammad Faisal Surgical Unit, Home Welfare Hospital, Dera Ismail Khan, Pakistan
Abstract
Background: Type 2 diabetes mellitus (DM) is a chronic disease requiring lifelong treatment. Therefore, as-sessment of the long-term safety and tolerability of newer therapeutic agents is of importance. The objective of this study was to compare safety and efficacy of sitagliptin with glimepiride in patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy. Material & Methods: Patients with type 2 DM inadequately controlled with metformin monotherapy were ran-domized to receive sitagliptin 100mg or glimepiride 2mg once daily as add-on therapy for 12 weeks. Primary end point was the number of patients achieving HbA1C
Publication Details
Page(s) 3-7
DOI DOI not available
Published Journal: Gomal Journal of Medical Sciences, Volume: 11, Issue: 1, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

28

Views